Feasibility of Internet Based Support (Carer eSupport) for Informal Caregivers of Patients With Head and Neck Cancer

February 15, 2024 updated by: Uppsala University

Carer eSupport: Rationale and Design of an Internet-based Support for Informal Caregivers of Individuals With Head and Neck Cancer

Informal caregivers to patients with head and neck cancer report that they are unprepared for caregiving, that they experience a high caregiver burden and a deteriorated health. The aim is to develop an internet based intervention for informal caregivers of individuals with head and neck cancer and evaluate the feasibility and acceptability of the intervention. The internet based intervention (Carer eSupport) will be based on scientific evidence, established theoretical frameworks and focus groups with caregivers and health care professionals. The feasibility and acceptability of Carer eSupport will be evaluated by 30 caregivers who will have access to Carer eSupport during one months. The feasibility and acceptability of Carer eSupport will be evaluated with quantitative and qualitative data.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Blekinge Län
      • Örebro, Blekinge Län, Sweden, 70185
        • Orebro University Hospital
    • Uppsala Län
      • Uppsala, Uppsala Län, Sweden, 75105
        • Uppsala University Hospital
    • Västerbottens Län
      • Umeå, Västerbottens Län, Sweden, 90737
        • Norrland University Hospital
    • Västra Götaland
      • Göteborg, Västra Götaland, Sweden, 41345
        • Sahlgrenska University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Informal caregivers (defined by the patients) to patients with head and neck cancer who are about to start treatment, undergoing treatment or have completed treatment within the past month.

Exclusion Criteria:

  • Confusion or dementia, inability to understand, speak or read Swedish.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Internet based support
Internet based support for informal caregivers to individuals who are undergoing treatment for head and neck cancer.
Carer eSupport is designed to prepare informal caregivers for caregiving, to decrease caregiver burden and prevent a deteriorated health.
Other Names:
  • Carer eSupport

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inclusion rate
Time Frame: 4 months
The proportion of caregivers who give informed consent for participation
4 months
Utilization of Carer eSupport
Time Frame: 2 months
The proportion of included caregivers who take use of Carer eSupport
2 months
Attrition
Time Frame: 3 months
The proportion of included caregivers who withdraw from the study
3 months
Completion of questionnaires
Time Frame: 3 months
The proportion of included caregivers who complete questionnaires
3 months
Perceived feasibility
Time Frame: Within 1 months after completion of testing Carer eSupport.
Qualitative data from semi-structured individual interviews exploring perceived feasibility of Carer eSupport.
Within 1 months after completion of testing Carer eSupport.
Perceived acceptability
Time Frame: Within 1 months after completion of testing Carer eSupport.
Qualitative data from semi-structured individual interviews exploring perceived acceptability of Carer eSupport.
Within 1 months after completion of testing Carer eSupport.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Preparedness for caregiving scale
Time Frame: Assessed at baseline and at 1 months after access to Carer eSupport
A brief 8-item self-report measure assessing preparedness for caregiving, a potential primary outcome in a future randomized controlled trial.
Assessed at baseline and at 1 months after access to Carer eSupport
Caregiver´s burden scale
Time Frame: Assessed at baseline and at 1 months after access to Carer eSupport.
A 22-item self-report measure assessing caregiver burden, a potential primary outcome in a future randomized controlled trial.
Assessed at baseline and at 1 months after access to Carer eSupport.
Short Form Health Survey (SF-36), v2.
Time Frame: Assessed at baseline and at 1 months after access to Carer eSupport.
A 36-item self-report measure assessing self-perceived health, a potential secondary outcome in a future randomized controlled trial.
Assessed at baseline and at 1 months after access to Carer eSupport.
The Depression Anxiety Stress Scale-21
Time Frame: Assessed at baseline and at 1 months after access to Carer eSupport.
A 21-item self-report measure assessing depression, anxiety, and stress, a potential secondary outcome in a future randomized controlled trial.
Assessed at baseline and at 1 months after access to Carer eSupport.
The Multidimensional fatigue inventory
Time Frame: Assessed at baseline and at 1 months after access to Carer eSupport.
A 20-item self-report measure assessing five dimensions of fatigue, a potential secondary outcome in a future randomized controlled trial.
Assessed at baseline and at 1 months after access to Carer eSupport.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Birgitta Johansson, Docent, Uppsala University, Department of Immunology, Genetics and pathology

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 17, 2023

Primary Completion (Actual)

September 30, 2023

Study Completion (Actual)

September 30, 2023

Study Registration Dates

First Submitted

August 24, 2021

First Submitted That Met QC Criteria

August 24, 2021

First Posted (Actual)

August 31, 2021

Study Record Updates

Last Update Posted (Actual)

February 16, 2024

Last Update Submitted That Met QC Criteria

February 15, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Carer eSupport

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There is no plan to make individual participant data (IPD) available to other researchers, since this is a feasibility study.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Head and Neck Cancer

Clinical Trials on Internet based support

3
Subscribe